期刊文献+

阻抑eIF-4E对大肠腺癌细胞乙酰肝素酶mRNA水平及其表达的影响 被引量:1

Effect of eIF-4E inhibition on heparanase mRNA and its expression in colon adenocarcinoma cell
下载PDF
导出
摘要 目的确定阻抑大肠腺癌LS-174T细胞中过量表达的真核细胞起始因子-4E(eIF-4E)是否促进乙酰肝素酶mRNA的降解,并改变其翻译表达水平。方法应用脂质体包裹与eIF-4E mRNA翻译起始点互补的反义寡聚核苷酸,转染处理人大肠腺癌细胞LS-174T。Western blotting和RT-PCR方法分别检测eIF-4E被阻抑后转录和翻译水平的改变。采用Northern blotting定量检测乙酰肝素酶mRNA的细胞内水平,Western blotting检测其蛋白表达水平的改变。结果反义寡聚核苷酸经脂质体转染LS-174T细胞后,eIF-4E基因表达明显受到抑制,其蛋白表达产物也显著下降。伴随eIF-4E被阻抑表达,Northern blotting结果显示乙酰肝素酶mRNA水平下降,且其蛋白翻译表达量也降低。结论阻抑eIF-4E影响LS-174T细胞乙酰肝素酶mRNA的稳定表达,促使其降解,并降低乙酰肝素酶表达。 Objective To verify whether inhibition of the overexpressed eukaryotic initiation factor-4E (eIF-4E) in human colon adenocarcinoma cell line LS-174T may facilitate the degradation of heparanase mRNA and alter the translation and expression levels of heparanase protein. Methods A 20-mer antisense s-oligodeoxynucleotide (asODN) targeted against the translation start site of eIF-4E mRNA was introduced into LS-174T cells by means of lipid-mediated DNA-transfection, followed by Western blotting analysis and reverse transcription-PCR to determine eIF-4E protein and mRNA levels, respectively. Northern methods was applied to determine heparanase mRNA expression level, with the alterations of heparanase expression assessed by Western blotting analysis. Results The 20-mer asODN against eIF-4E specifically and significantly inhibited eIF-4E protein expression, and as a result, a significant reduction in heparanase mRNA level was observed by Northern blotting in conjunction with significantly decreased heparanase protein expression. Conclusion The inhibition of eIF-4E strongly reduces the stability of heparanase mRNA in colon adenocarcinoma cell line LS-174T and results in an apparent reduction in the expression of heparanase protein.
出处 《第一军医大学学报》 CSCD 北大核心 2003年第7期655-658,共4页 Journal of First Military Medical University
基金 国家骨干教师基金 广东省自然科学基金(010643)~~
关键词 大肠腺癌 乙酰肝素酶 mRNA EIF-4E 真核细胞起始因子4E 基因表达 oligodeoxynucleotides eukaryotic initiation factor 4E heparanase RNA, messenger colorectal neoplasms adeno- carcinoma
  • 相关文献

参考文献13

  • 1Zimmer SG, De-Benedetti A, Graff JR. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis [J].Anticancer Res, 2000, 20(3A): 1343-51.
  • 2Rosenwald IB, Chen JJ, Wang S, et al. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis[J]. Oncogene, 1999, 18(15): 2507-17.
  • 3de-Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, et al. Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F[J], Mol Cell Biol, 1991, 11(11): 5435-45.
  • 4Anthony B, Carter P, DeBenedetti A. Overexpression of the protooncogene/translation factor 4E in breast-carcinoma cell lines [J]. Int J Cancer, 1996, 65(6): 858-63.
  • 5Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual [M]. New York: Cold Springer Harbor Lab Press, 1989.362, 888.
  • 6Kussie PH, Hulmes JD, Ludwig DL et al. Cloning and functional expression of a human heparanase gene [ J ]. Biochem Biophys Res Commua, 1999, 261(1): 183-7.
  • 7Hulett MD, Hornby JR, Ohms S J, et al. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase [J].Biochemistry. 2000. 39(51): 15659-67.
  • 8Rousseau D, Kaspar R, Rosenwald I, et al. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E[J]. Proc Natl Acad Sci USA, 1996, 93(3): 1065-70.
  • 9Dehlin E, Wormington M, Korner CG, et al. Cap-dependent deadenylation of mRNA[J]. EMBO J, 2000, 19(5): 1079-86.
  • 10Chang M, French-Cornay D, Fan HY, et al. A complex containing RNA polymerase Ⅱ, Paflp, Cdc73p, Hprlp, and Ccr4p plays a role in protein kinase C signaling[J]. Mol Cell Biol, 1999, 19(2): 1056-67.

同被引文献6

  • 1Eccles SA. Heparanase: breaking down barriers in tumors.Nat Med,1999, 5(7) :735
  • 2Vlodavsky I,Elkin M,Pappo O,et al. Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Isr Med Assoe J,2000,2 Suppl:37
  • 3Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase:gene cloning, expression and function in tumor progression and metastasis. Nat Med ,1999,5 (7) :793
  • 4Fox SB, Gatter KC, Harris AL. Tumor angiogenesis. J Pathol, 1996, 179(3):232
  • 5Zhang QX, Magovern C J, Mack CA,et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res, 1997,67 (2): 147
  • 6Neufeld G,Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor and its receptor. FASEB J,1999,13( 1 ) :9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部